Posted on August 27, 2021 Health Canada Approves MYINFLATM (Colchicine 0.5 mg Extended-Release Tablets), a New Repurposed Treatment for Cardiovascular Disease Read More
Posted on November 16, 2019 Pharmascience inc. contributes to the Montreal Heart Institute’s Colchicine Cardiovascular Outcome Trial (COLCOT) Read More
Posted on November 12, 2018 PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award Read More
Posted on February 20, 2018 PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals Read More
Posted on September 22, 2017 PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada Read More